• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NGS 5.00% 19.0¢

NUTRITIONAL GROWTH SOLUTIONS LTD - Corporate Spotlight

NGS is a global nutritional health company focused on the well-being of children. NGS... NGS is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into paediatric nutrition at Schneider Children's Medical Centre in Israel.More

Corporate Spotlight

NGS is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into paediatric nutrition at Schneider Children's Medical Centre in Israel.
View the full Corporate Spotlight arrow Created with Sketch.

NGS talks new product lines and China distribution

NGS SUPPLEMENT SHOWS POSITIVE RESULTS

arrow-down-2 Created with Sketch.

Nutritional Growth Solutions’ (ASX:NGS) growth supplement shows positive results

Consumer Discretionary

ASX:NGS
Nutritional Growth Solutions (ASX:NGS) - Non Executive Chairman, Brian Leedman - The Market Herald
Non Executive Chairman, Brian Leedman
Source: Nutritional Growth Solutions

  • Nutritional Growth Solutions (NGS) announces positive results from a 12-month clinical trial on its Grow Daily Boys 10+ formula
  • The trial assessed the formula's effect on height, weight and body composition in 160 healthy, lean and short males aged 10 to 14.5 years
  • Those who consumed the formula over six months showed an increase to their weight, BMI and muscle mass compared to those who had the placebo
  • Managing Director and CEO Liron Fendell says the results verify the positive effect its Grow Daily Boys 10+ formula has on growth for pre-adolescent boys

Nutritional Growth Solutions (NGS) has announced positive results from a clinical trial on its Grow Daily Boys 10+ formula.


The 12-month randomised, placebo-controlled trial assessed the formula's effect on height, weight and body composition in 160 healthy, lean and short males aged between 10 and 14.5 years.


The study was carried out in two stages. The first was a double-blind intervention with the nutritional formula or a placebo and the second stage administered the nutritional formula to all participants.


Pleasingly for NGS, the results found that those who consumed Grow Daily Boys 10+ over six months showed an increase to their weight, BMI and muscle mass, compared to those who consumed the placebo supplement.


Older participants aged over 11.4 years who consumed the formula maintained their height increase rate while those taking the placebo showed a decrease in their rate of height increase.


Lead researcher of the study, Michal Yackobovitch-Gavan, said the trial evaluated the importance of nutrition for pre-adolescents.


"Intervention with a multi-nutrient, protein-rich formula was effective at increasing weight, fat-free-mass, muscle mass, and BMI in short and lean pre-pubertal male adolescents," Dr Yackobovitch-Gavan said. "It also prevented the expected decline in height increase rate in older participants."


NGS's Managing Director and CEO Liron Fendell commented on the results.


"As we launch Grow Daily Boys 10+ to market, it is great to have the clinical trial findings to verify the positive effect on growth for teen and pre-teen boys," she said.


"The make-up of nutrients required for optimal growth changes throughout a child’s growing years and this is why we created a formulation specifically for boys aged 10 and over. Our new Grow Daily Boys 10+ range contains all the essential micronutrients, such as calcium and iron with high protein needed for optimal growth in pre-teens."


Read the Full Article on The Market Herald here

NGS ENTERS TRADING HALT

arrow-down-2 Created with Sketch.

Nutritional Growth Solutions (ASX:NGS) halts trade following Grow Daily Boys 10+ launch

ASX:NGS
Nutritional Growth Solutions (ASX:NGS) - Non Executive Chairman, Brian Leedman - The Market Herald
Non Executive Chairman, Brian Leedman
Source: Nutritional Growth Solutions

  • Nutritional Growth Solutions (NGS) enters a trading halt pending an upcoming capital raising
  • The company will remain in the halt until August 30 or when more details regarding the raise are released, whichever occurs first
  • This trading halt follows the launch of Grow Daily Boys+ for pre-teens and teenage boys
  • Grow Daily Boys 10+ is formulated with micro and macro nutrients to support the physical development of young males

Nutritional Growth Solutions (NGS) has entered a trading halt pending an upcoming capital raising.


The company will remain in the halt until August 30 or when more details regarding the raise are released, whichever occurs first.


NGS is yet to disclose how much it intends to raise or what it will use the funds for once received.


This trading halt follows the launch of Grow Daily Boys+ for pre-teens and teenage boys on August 23.


Grow Daily Boys 10+ is NGS's newest product and is formulated with a blend of micro and macro nutrients to support the physical development of young males.


Initially, it will be launched in the US with further markets to follow shortly.


This is the first trading halt the company has entered since listing on the ASX in November 2020 following a $7 million initial public offering.


The funds were raised through the issue of more than 35 million shares at 20 cents.


Read the Full Article on The Market Herald here

NGS POSTS RECORD HALF YEAR REVENUE

arrow-down-2 Created with Sketch.

Nutritional Growth Solutions (ASX:NGS) posts record half year revenue

Consumer Discretionary

ASX:NGS
Nutritional Growth Solutions (ASX:NGS) finds ADHD trial location
Source: Nutritional Growth Solutions.

  • Nutritional Growth Solutions (NGS) sees a record half year revenue for the six months ending June 30 2021
  • The company's half year revenue came to US$1.8 million (A$2.5 million), which is up 83 per cent from June 30 2020
  • This result was driven by continued growth in the key North American market, as well as launching its Healthy Height brand in China and Italy
  • NGS ended the period with a cash balance of US$2.7 million (A$3.7 million)

Nutritional Growth Solutions (NGS) has seen a record half year revenue for the six months ending June 30 2021.


The company's half year revenue totalled US$1.8 million (A$2.5 million), which is up 83 per cent from this time last year. This result was driven by continued growth in the key North American market, as well as launching its Healthy Height nutritional supplement brand in China and Italy.


However, NGS incurred a loss of US$2.2 million (A$3 million) for the first half as it increased investment in research, marketing and distribution.


At the end of the period, NGS had a cash balance of US$2.7 million (A$3.7 million).


Just recently, NGS signed a supply agreement to stock its range in Chemist Warehouse China.


CEO and Managing Director, Liron Fendell, was pleased with the progress during the six months ending June 30.


"The first half of 2021 has been instrumental to the international growth of Nutritional Growth Solutions as a global provider of nutritional supplements that are scientifically formulated by paediatric doctors, patented and clinically proven to support growth development in children, and our Healthy Height brand," Mr Fendall said.


"Lastly, we have recommenced all clinical trials that were placed on hold due to COVID-19 and we look forward to providing an update of these findings once they are available."


Read the Full Article on The Market Herald here

NGS SUPPLIES TO CHEMIST WAREHOUSE CHINA

arrow-down-2 Created with Sketch.

Nutritional Growth Solutions (ASX:NGS) supplies Healthy Height to Chemist Warehouse China

Consumer Discretionary

ASX:NGS
Nutritional Growth Solutions (ASX:NGS) - Managing Director & CEO, Liron Fendell - The Market Herald
Managing Director & CEO, Liron Fendell
Source: Israel Trade Commission Australia

  • Nutritional Growth Solutions (NGS) signs a supply agreement to stock its range in Chemist Warehouse China
  • Under the deal to start immediately, the company will also stock its Healthy Height shake range on the Chemist Warehouse China T-Mall Global Store
  • NGS says Healthy Height has been clinically proven to support growth development in children
  • The agreement will run for a 12 month period and can be terminated by either party with a one month notice in writing

Nutritional Growth Solutions (NGS) has signed a supply agreement to stock its range in Chemist Warehouse China.


Under the agreement, NGS will stock its Healthy Height shake range across shelves in Chemist Warehouse stores in China as well as on the Chemist Warehouse China T-Mall Global Store.


NGS says the Healthy Height shake range has been clinically proven to increase growth development in children.


The agreement will begin immediately and there are no conditions to be met prior to beginning.


It will run for a 12 month period and can be terminated by either party with a one month notice in writing.


Additionally, it marks a key milestone in NGS's China expansion strategy and follows the recent appointment of a Commercial Director in China.


CEO and Managing Director Liron Fendell is excited to have the company's products being stocked across China.


"We are excited to embark on this new partnership with Chemist Warehouse China, and launch the Healthy Height shake range across its high performing physical and online stores in China," Ms Fendell said.


"Whilst the agreement does not contain minimum order sizes and the company cannot provide a revenue projection at this stage, this agreement represents a significant achievement for the company as an important distribution channel into China."


Read the Full Article on The Market Herald here

NGS FINDS ADHD TRIAL LOCATION

arrow-down-2 Created with Sketch.

Nutritional Growth Solutions (ASX:NGS) finds ADHD trial location

Health Care

ASX:NGS
Nutritional Growth Solutions (ASX:NGS) finds ADHD trial location
Source: Nutritional Growth Solutions.

  • Nutritional Growth Solutions (NGS) will carry out a clinical trial of Healthy Height on kids with ADHD at the Schneider Children’s Medical Centre in Israel
  • The Healthy Height nutritional treatment is already proven to improve the height and weight in short and lean kids aged three to nine by up to 34 per cent
  • This new trial will test whether using NGS's Healthy Height increases growth in children treating ADHD using stimulant medication
  • Studies show kids with ADHD who are being treated with these stimulants may suffer a reduction in height growth

Nutritional Growth Solutions (NGS) will carry out a clinical trial of Healthy Height on kids with ADHD at the Schneider Children’s Medical Centre in Israel.


The Healthy Height nutritional treatment has already been proven to improve the height and weight in short and lean kids aged three to nine by up to 34 per cent.


NGS now wants to test whether it can help children with ADHD who are on stimulants, as studies show these kids may suffer reduced height gains.


The company said it had signed an agreement with Schneider, where Healthy Height was first created, to test between 70 and 140 children.


All of the trial participants will be aged under 10, diagnosed with ADHD and being treated using stimulant medication.


Half of them will supplement their diet with the Healthy Height formula, while the other 50 per cent will take a placebo product.


Commenting on the trial, NGS CEO and Managing Director Liron Fendell said he was hopeful Healthy Heights would help these children.


"ADHD is a prevalent disorder globally with treatment’s adverse side effects including decreased appetite," Mr Fendell said.


"In the US, insurance coverage decisions by commercial insurance and government payers are tied to medical necessity and discreet diagnoses.


"If the trial provides clear evidence that Healthy Height supports children with an ADHD diagnosis who have been prescribed meds achieve normal growth and counteract the negative effects of the drugs, we believe the payers will be more likely to cover Healthy Height alongside an ADHD diagnosis."


Read the Full Article on The Market Herald here

ABOUT US

arrow-down-2 Created with Sketch.


NGS is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into paediatric nutrition at Schneider Children's Medical Centre in Israel.



Visit their website for more info: https://ngsolutions.co/

VIDEOS

arrow-down-2 Created with Sketch.

Nutritional Growth Solutions (ASX:NGS) talks new product lines and China distribution



Nutritional Growth Solutions Ltd (ASX:NGS) addressing the untapped children’s supplement market


(20min delay)
Last
19.0¢
Change
-0.010(5.00%)
Mkt cap ! $22.35M
Open High Low Value Volume
19.5¢ 19.5¢ 19.0¢ $22.16K 116.1K

Buyers (Bids)

No. Vol. Price($)
3 43875 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 111967 2
View Market Depth
Last trade - 16.10pm 23/09/2021 (20 minute delay) ?
(live)
Last
19.0¢
  Change
-0.010 ( 2.56 %)
Open High Low Volume
18.5¢ 19.0¢ 18.5¢ 129660
Last updated 15.48pm 23/09/2021 (live) ?
NGS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.